NL-OMON44925招募中不适用
International CIDP Outcome Study A prospective study on clinical and biological predictors of disease course and outcome in CIDP - ICOS
eurologie0 个研究点目标入组 225 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •1. The ICOS is using the EFNS/PNS criteria (clinical and electrophysiological criteria) for the diagnosis of CIDP.
- •Three categories of patients are eligible for the ICOS:
- •a) Patients fulfilling the clinical criteria and the definite, probable or possible electrophysiological criteria defined in supplement 1.
- •b) Patients fulfilling the clinical criteria and at least two supportive criteria defined in supplement 1.
- •c) Patients fulfilling the clinical criteria for pure sensory CIDP and at least two supportive criteria defined supplement 2 (if not fulfilling the electrophysiological criteria).
- •2. Being able and willing to conduct a follow-up of at least 2 years.
- •3. Informed consent.
排除标准
- •No exclusion criteria
研究者
相似试验
Enrolling By Invitation
不适用
A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) PatientsPulmonary Arterial HypertensionNCT06445673AOP Orphan Pharmaceuticals AG110
招募中
1 期
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastinestandard risk ALK-positive anaplastic large cell lymphoma (ALCL)CTIS2022-501454-11-00GPOH gGmbH132
招募中
3 期
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of VinblastineDRKS00023541Gesellschaft für pädiatrische Hämatologie und Onkologie (GPOH) gGmbH106
尚未招募
3 期
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine.NL-OMON51961German Pediatric Oncology Group (GPOH) gGmbH10
进行中（未招募）
1 期
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastinestandard risk ALK-positive anaplastic large cell lymphoma (ALCL)EUCTR2017-002935-40-NLGesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) gGmbH106